These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 2307857

  • 1. Establishment of a human cutaneous T-cell lymphoma in C.B-17 SCID mice.
    Charley MR, Tharp M, Locker J, Deng JS, Goslen JB, Mauro T, McCoy P, Abell E, Jegasothy B.
    J Invest Dermatol; 1990 Mar; 94(3):381-4. PubMed ID: 2307857
    [Abstract] [Full Text] [Related]

  • 2. Adoptive immunity in immune-deficient scid/scid mice. I. Differential requirements of naive and primed lymphocytes for CD4+ T cells during rejection of minor histocompatibility antigen-disparate skin grafts.
    Roopenian DC, Anderson PS.
    Transplantation; 1988 Dec; 46(6):899-904. PubMed ID: 2905088
    [Abstract] [Full Text] [Related]

  • 3. Use of a SCID mouse/human lymphoma model to evaluate cytokine-induced killer cells with potent antitumor cell activity.
    Schmidt-Wolf IG, Negrin RS, Kiem HP, Blume KG, Weissman IL.
    J Exp Med; 1991 Jul 01; 174(1):139-49. PubMed ID: 1711560
    [Abstract] [Full Text] [Related]

  • 4. Multiple defects in innate and adaptive immunologic function in NOD/LtSz-scid mice.
    Shultz LD, Schweitzer PA, Christianson SW, Gott B, Schweitzer IB, Tennent B, McKenna S, Mobraaten L, Rajan TV, Greiner DL.
    J Immunol; 1995 Jan 01; 154(1):180-91. PubMed ID: 7995938
    [Abstract] [Full Text] [Related]

  • 5. New immunodeficient (nude-scid, beige-scid) mice as excellent recipients of human skin grafts containing intraepidermal neoplasms.
    Takizawa Y, Saida T, Tokuda Y, Dohi S, Wang YL, Urano K, Hioki K, Ueyama Y.
    Arch Dermatol Res; 1997 Mar 01; 289(4):213-8. PubMed ID: 9143737
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. NOD/LtSz-Rag1null mice: an immunodeficient and radioresistant model for engraftment of human hematolymphoid cells, HIV infection, and adoptive transfer of NOD mouse diabetogenic T cells.
    Shultz LD, Lang PA, Christianson SW, Gott B, Lyons B, Umeda S, Leiter E, Hesselton R, Wagar EJ, Leif JH, Kollet O, Lapidot T, Greiner DL.
    J Immunol; 2000 Mar 01; 164(5):2496-507. PubMed ID: 10679087
    [Abstract] [Full Text] [Related]

  • 9. Evidence that specific cellular immunity cannot account for death of Mus caroli embryos transferred to Mus musculus with severe combined immune deficiency disease.
    Crepeau MA, Croy BA.
    Transplantation; 1988 Jun 01; 45(6):1104-10. PubMed ID: 2968010
    [Abstract] [Full Text] [Related]

  • 10. Evidence of functional lymphocytes in some (leaky) scid mice.
    Bosma GC, Fried M, Custer RP, Carroll A, Gibson DM, Bosma MJ.
    J Exp Med; 1988 Mar 01; 167(3):1016-33. PubMed ID: 3280724
    [Abstract] [Full Text] [Related]

  • 11. Engraftment of precursor lesions of human cutaneous neoplasms onto C.B-17 SCID mice: a useful in vivo experimental model of carcinogenesis in human skin.
    Takizawa Y, Saida T, Tokuda Y, Dohi S, Ikegawa S, Ueyama Y.
    Arch Dermatol Res; 1995 Mar 01; 287(3-4):237-41. PubMed ID: 7598527
    [Abstract] [Full Text] [Related]

  • 12. Characterization of B lymphocyte lineage progenitor cells from mice with severe combined immune deficiency disease (SCID) made possible by long term culture.
    Witte PL, Burrows PD, Kincade PW, Cooper MD.
    J Immunol; 1987 Apr 15; 138(8):2698-705. PubMed ID: 3104473
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Growth and invasion of human melanomas in human skin grafted to immunodeficient mice.
    Juhasz I, Albelda SM, Elder DE, Murphy GF, Adachi K, Herlyn D, Valyi-Nagy IT, Herlyn M.
    Am J Pathol; 1993 Aug 15; 143(2):528-37. PubMed ID: 8342600
    [Abstract] [Full Text] [Related]

  • 15. Allograft and xenograft rejection in C3H/SCID mice. A new model for the study of non-T cell graft rejection mechanisms.
    Marcus H, FActorovich Y, Kulova L, Denes L, Segal H, David M, Burakova T, Reisner Y.
    Transplantation; 1996 Mar 15; 61(5):777-83. PubMed ID: 8607183
    [Abstract] [Full Text] [Related]

  • 16. Severe combined immunodeficiency (SCID) in the mouse. Pathology, reconstitution, neoplasms.
    Custer RP, Bosma GC, Bosma MJ.
    Am J Pathol; 1985 Sep 15; 120(3):464-77. PubMed ID: 2412448
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Rejection of bone marrow allografts by mice with severe combined immune deficiency (SCID). Evidence that natural killer cells can mediate the specificity of marrow graft rejection.
    Murphy WJ, Kumar V, Bennett M.
    J Exp Med; 1987 Apr 01; 165(4):1212-7. PubMed ID: 3549961
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.